https://www.globenewswire.com/news-release/2024/09/12/2944984/0/en/ITM-Obtains-Exclusive-Worldwide-License-from-Debiopharm-for-CA-IX-Targeted-Peptide-based-Radiopharmaceutical-Programs-Targeting-Solid-Tumors.html?pdf=1
Journal of Exposure Science & Environmental Epidemiology – Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident…
PURPOSEPrecision oncology connects highly complex diagnostic procedures with patient histories to identify individualized treatment options in interdisciplinary molecular tumor boards (MTBs). Detailed data on MTB-guided…
Data support the IGG signature, especially its key gene subset, as a potential marker of sustained antitumor activity in breast cancer.
R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 trial for cancer treatment.
This Cancer Tag Ontology page’s aim is to develop and organize hashtags to promote better cancer care for patients, caregivers, healthcare professionals and all with…
This cohort study evaluates the genomic profile of patients with small-bowel adenocarcinoma compared with colorectal cancer and gastric carcinoma.
Harmful chemicals in sewage sludge spread on pasture as fertilizer pose a risk to people who regularly consume milk, beef and other products from those…
Most deaths avoided from common cancers between 1975 and 2020 could be traced to prevention and screening efforts.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
